Magellan adopts new guidelines for depressive disorders and schizophrenia
Magellan’s clinical taskforce recently adopted two external clinical practice guidelines (CPGs). These guidelines serve as the evidence-based framework for practitioners’ clinical decision-making for the treatment of patients.
Highlights of the 2021 changes:
Magellan most recently adopted the American Psychological Association Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), in addition to readopting the American Psychiatric Association (APA) Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition (APA, 2010).
In addition, Magellan adopted the American Psychiatric Association Practice Guideline for the Treatment of Patients with Schizophrenia, Third Edition (2020). The Magellan introduction to the second edition of the APA’s guideline has been retired.
Previously adopted guidelines
The Magellan taskforce removed some previously adopted or developed guidelines from their regular review and update; however, these remain available to providers on our website as portions of the documents are pertinent to current clinical practice. The CPGs for eating disorders, panic disorder, and bipolar disorder were recently moved to this status.
Have feedback to share?
Magellan’s adopted guidelines are intended to augment, not replace, sound clinical judgment. We welcome your feedback and will consider all suggestions and recommendations in our next review. You may submit comments to your regional Magellan provider advisory group, medical director or to CPG@MagellanHealth.com.